These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24564974)

  • 21. A Systematic Review of the Economic Burden of Type 2 Diabetes in Malaysia.
    Ganasegeran K; Hor CP; Jamil MFA; Loh HC; Noor JM; Hamid NA; Suppiah PD; Abdul Manaf MR; Ch'ng ASH; Looi I
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32784771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000.
    O'Brien JA; Patrick AR; Caro J
    Clin Ther; 2003 Mar; 25(3):1017-38. PubMed ID: 12852716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.
    Palmer AJ; Roze S; Valentine WJ; Minshall ME; Foos V; Lurati FM; Lammert M; Spinas GA
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S5-26. PubMed ID: 15324513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictions Burden of Diabetes and Economics Cost: Contributing Risk Factors of Changing Disease Prevalence and its Pandemic Impact to Qatar.
    Bener A; Al-Hamaq AO
    Exp Clin Endocrinol Diabetes; 2016 Sep; 124(8):504-511. PubMed ID: 27023007
    [No Abstract]   [Full Text] [Related]  

  • 25. Challenges in diabetes management in Indonesia: a literature review.
    Soewondo P; Ferrario A; Tahapary DL
    Global Health; 2013 Dec; 9():63. PubMed ID: 24299164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.
    van der Linden MW; Plat AW; Erkens JA; Emneus M; Herings RM
    Value Health; 2009 Sep; 12(6):909-14. PubMed ID: 19508664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes, healthcare cost and loss of productivity in Sweden 1987 and 2005--a register-based approach.
    Bolin K; Gip C; Mörk AC; Lindgren B
    Diabet Med; 2009 Sep; 26(9):928-34. PubMed ID: 19719715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Addressing the burden of diabetes.
    Seaquist ER
    JAMA; 2014 Jun; 311(22):2267-8. PubMed ID: 24915253
    [No Abstract]   [Full Text] [Related]  

  • 29. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Technology and the issue of cost/benefit in diabetes.
    Giannini C; Mohn A; Chiarelli F
    Diabetes Metab Res Rev; 2009 Sep; 25 Suppl 1():S34-44. PubMed ID: 19662616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Direct and indirect diabetes costs in the world].
    Logminiene Z; Norkus A; Valius L
    Medicina (Kaunas); 2004; 40(1):16-26. PubMed ID: 14764977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Projection of the burden of type 2 diabetes mellitus in Germany: a demographic modelling approach to estimate the direct medical excess costs from 2010 to 2040.
    Waldeyer R; Brinks R; Rathmann W; Giani G; Icks A
    Diabet Med; 2013 Aug; 30(8):999-1008. PubMed ID: 23506452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes in Argentina: cost and management of diabetes and its complications and challenges for health policy.
    Caporale JE; Elgart JF; Gagliardino JJ
    Global Health; 2013 Oct; 9():54. PubMed ID: 24168330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health care use and costs in the decade after identification of type 1 and type 2 diabetes: a population-based study.
    Johnson JA; Pohar SL; Majumdar SR
    Diabetes Care; 2006 Nov; 29(11):2403-8. PubMed ID: 17065675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and complications of diabetes mellitus in Northern Africa, a systematic review.
    Bos M; Agyemang C
    BMC Public Health; 2013 Apr; 13():387. PubMed ID: 23617762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cost-effectiveness of intensive therapy for diabetes mellitus.
    Herman WH; Dasbach EJ; Songer TJ; Eastman RC
    Endocrinol Metab Clin North Am; 1997 Sep; 26(3):679-95. PubMed ID: 9314022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
    Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
    Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 3C study: coverage cost and care of type 1 diabetes in China--study design and implementation.
    McGuire H; Kissimova-Skarbek K; Whiting D; Ji L
    Diabetes Res Clin Pract; 2011 Nov; 94(2):307-10. PubMed ID: 22056720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic cost of diabetes in the Eastern Mediterranean region countries: A meta-analysis.
    Ansari-Moghaddam A; Setoodehzadeh F; Khammarnia M; Adineh HA
    Diabetes Metab Syndr; 2020; 14(5):1101-1108. PubMed ID: 32653635
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.